SECTION .4500 – substance abuse comprehensive outpatient treatment program

 

10A NCAC 27G .4501      Scope

(a)  A substance abuse comprehensive outpatient treatment program (SACOT) is one that provides a multi-faceted approach to treatment in an outpatient setting for adults with a primary substance-related diagnosis who require structure and support to achieve and sustain recovery.

(b)  Treatment support activities may be adapted or specifically designed for persons with physical disabilities, co-occurring disorders including mental illness or developmental disabilities, pregnant women, chronic relapse, and other homogenous groups.

(c)  SACOT shall have a structured program, which includes the following services:

(1)           individual counseling;

(2)           group counseling;

(3)           family counseling;

(4)           strategies for relapse prevention to include community and social support systems in treatment;

(5)           life skills;

(6)           crisis contingency planning;

(7)           disease management;

(8)           service coordination activities; and

(9)           biochemical assays to identify recent drug use (e.g. urine drug screens).

(d)  The treatment activities specified in Paragraph (c) of this Rule shall emphasize the following:

(1)           reduction in use and abuse of substances or continued abstinence;

(2)           the understanding of addictive disease;

(3)           development of social support network and necessary lifestyle changes;

(4)           educational skills;

(5)           vocational skills leading to work activity by reducing substance abuse as a barrier to employment;

(6)           social and interpersonal skills;

(7)           improved family functioning;

(8)           the negative consequences of substance abuse; and

(9)           continued commitment to recovery and maintenance program.

 

History Note:        Authority G.S. 122C-26; 143B-147;

Eff. April 1, 2006;

Pursuant to G.S. 150B-21.3A, rule is necessary without substantive public interest Eff. July 20, 2019.